Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 211,141,084 papers from all fields of science
Search
Sign In
Create Free Account
Extended Release Oral Capsule
Known as:
Extended-release capsule
, Capsule, extended release
, XR Cap
Expand
A capsule designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce dosing frequency.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
12 HR Acetazolamide 500 MG Extended Release Oral Capsule [Diamox]
12 HR Aspirin 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule
12 HR Aspirin 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule [Aggrenox]
12 HR Carbamazepine 100 MG Extended Release Oral Capsule
Expand
Broader (1)
Pills
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Regenerated cellulose capsules for controlled drug delivery: Part III. Developing a fabrication method and evaluating extemporaneous utility for controlled-release.
B. Bhatt
,
Vijay Kumar
European Journal of Pharmaceutical Sciences
2016
Corpus ID: 25716287
Review
2015
Review
2015
Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?
M. Ehret
,
K. Chamberlin
Clinical Therapeutics
2015
Corpus ID: 206811049
Highly Cited
2015
Highly Cited
2015
Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa…
A. Hsu
,
Hsuan-Ming Yao
,
Suneel K. Gupta
,
N. Modi
Journal of clinical pharmacology
2015
Corpus ID: 9291780
IPX066 (extended‐release carbidopa‐levodopa [ER CD‐LD]) is an oral extended‐release capsule formulation of carbidopa and levodopa…
Expand
Review
2013
Review
2013
Levomilnacipran Extended Release: First Global Approval
P. Hair
,
F. Cameron
,
Karly P Garnock-jones
Drugs
2013
Corpus ID: 965954
Pierre Fabre and Forest Laboratories are developing levomilnacipran extended release (ER) [FETZIMA™], an enantiomer of…
Expand
2013
2013
The use of high-dose insulin therapy and intravenous lipid emulsion to treat severe, refractory diltiazem toxicosis in a dog.
Barbara L Maton
,
Erin E Simmonds
,
Justine A. Lee
,
Amy J. Alwood
Journal of Veterinary Emergency and Critical Care
2013
Corpus ID: 7244556
OBJECTIVE To describe the novel use of high-dose insulin (HDI) therapy and intravenous lipid emulsion (ILE) to treat refractory…
Expand
2010
2010
Optimization and In vivo Pharmacokinetic Study of a Novel Controlled Release Venlafaxine Hydrochloride Three-Layer Tablet
Ahmed A. Aboelwafa
,
E. B. Basalious
AAPS PharmSciTech
2010
Corpus ID: 21106778
Several matrix tablet formulations (hydrophilic-based, wax-based, and three-layer tablets) were designed for controlling the…
Expand
2008
2008
Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study.
B. Patel
,
N. Sharma
,
M. Sanyal
,
P. Shrivastav
Journal of Pharmaceutical and Biomedical Analysis
2008
Corpus ID: 5797791
2008
2008
New Dissolution Method for Mesalamine Tablets and Capsules
M. Chuong
,
J. M. Christensen
,
J. Ayres
2008
Corpus ID: 8220852
Dissolution methods are different for extended-release mesalamine capsules (pH 7.5 only) and delayed-release tablets (pH 1.4, 6.0…
Expand
Review
2007
Review
2007
Displacement of Serotonin and Dopamine Transporters by Venlafaxine Extended Release Capsule at Steady State: A [123I]2β-Carbomethoxy-3β-(4-Iodophenyl)-Tropane Single Photon Emission Computed…
Yili Shang
,
M. Gibbs
,
+5 authors
J. F. Rogers
Journal of Clinical Psychopharmacology
2007
Corpus ID: 25239273
Both positron emission tomography and single photon emission computed tomography (SPECT) studies suggest that saturation of…
Expand
Highly Cited
2002
Highly Cited
2002
A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder.
J. Biederman
,
F. López
,
S. Boellner
,
Mark C. Chandler
Pediatrics
2002
Corpus ID: 26045428
OBJECTIVE SLI381 (Adderall XR) is a 2-component extended-release capsule formulation of Adderall designed to produce a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE